GlobeNewsWire
30 Sept 2026, 20:42 UTC · 3h ago
Standard BioTools Provides Update on Sale of Mass Cytometry Business
Verdict
Headline takes no side. We score LAB +0.60 across three claims — strongly bullish.
- Expected · LAB
+0.60strongly bullish
−1 bearish0bullish +1More positive than 78% of ticker scores this week
- Actual





